PROPHYLACTIC PLATELET TRANSFUSIONS BEFORE LUMBAL PUNCTURE
Abstract
BACKGROUND Prophylactic platelet concentrate (PC) transfusions may result in complications andincrease costs of treatment. It has not been shown that thrombocytopenia increase thepossibility of lumbar puncture (LP) related bleedings and that platelet transfusions reducethe risk of these complications. METHODS and 51 patients were included into the retrospective study. We wanted to find out how often thepatients LP was performed at platelet number < 50 × 109/L, how often the PC was used and whichwere the complications. The patients were divided into 3 groups according to the plateletnumber (group 1: ? 10 × 109/L; group 2: 11–20 × 109/L; group 3: 21–49 × 109/L). RESULTS 61 (6/19/36) and 74 (19/23/32) LPs were performed in the individual groups of the patients considering results of the platelet number measured with analyser and chamber respectively. The PC transfusions were used before LP at 5/6 (analyzer) and 9/19 (chamber)patients in group 1, at 7/19 (analyzer) and 3/23 (chamber) patients in group 2, and at2/36 (analyzer) and 1/32 (chamber) patients at group 3. Complications were not detectedin any of groups. CONCLUSIONS Our results confirm results of previous studies in which the safety of LP at platelet number> 10 × 109/L was confirmedDownloads
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
